Women who inject drugs face pervasive violence - and almost never seek medical help for it

Violence against women who inject drugs is not a hidden problem. It is a documented, studied, and persistently unaddressed one. A mixed-methods cohort study published in JAMA Network Open adds to that documentation with data from Australia, finding that violence against women in this population is pervasive, severe, and almost never met with adequate healthcare.

What the study found

The research, led by Ashleigh Cara Stewart at the Burnet Institute in Melbourne, combined quantitative survey data with qualitative interviews to capture both the scale and the lived experience of violence among Australian women who inject drugs. The central findings are blunt: violence was widespread across the cohort, encompassing physical, sexual, and emotional abuse, and the severity was high.

Yet rates of seeking healthcare for violence-related injuries or trauma remained remarkably low. The reasons are not mysterious, though they are multiple. Women in this population face intersecting barriers that stack against help-seeking: criminalization of drug use creates fear of law enforcement involvement, stigma from healthcare providers discourages contact with medical services, unstable housing and financial precarity limit access, and past negative experiences with institutions erode trust.

Intersecting vulnerabilities

Women who inject drugs occupy a space where multiple forms of marginalization converge. Drug use stigma, gender-based violence, poverty, and often histories of incarceration or child removal create a compound disadvantage that standard domestic violence services are rarely designed to address. The women in this study did not simply choose not to seek help. They operated within systems that made seeking help risky, humiliating, or practically impossible.

This dynamic is well-established in the research literature, but it persists in part because policy responses to drug use and violence against women tend to operate in separate silos. Drug policy focuses on harm reduction or criminalization. Violence policy focuses on shelters, protection orders, and counseling. The intersection - where a woman's drug use makes her more vulnerable to violence and simultaneously less able to access violence services - falls through the gap between the two.

What would help

The researchers argue that recognition of the burden of violence in this population is a critical first step toward tailored responses. That means violence screening integrated into harm reduction services and drug treatment programs, rather than expecting these women to navigate mainstream domestic violence pathways. It means training healthcare workers to respond to drug-using women without judgment. And it means designing services that account for the realities of criminalization, housing instability, and distrust.

What the study cannot show

The press release provides limited detail on the cohort's size, the specific prevalence figures, or the types of violence measured. As a mixed-methods study based in Australia, the findings may not translate directly to other countries with different drug policies, healthcare systems, or cultural contexts. The qualitative component provides depth but not generalizability. And the study describes a problem more than it tests a solution - the interventions suggested are reasonable but unproven in this specific population.

Still, the message is clear: a population already marginalized by drug use and gender is being further harmed by violence, and the systems that should protect them are not reaching them.